In 2003 a group of Swedish researchers reported that 63 out of a group of 71 melanoma patients, or 89% of the group, had mutations in either the NRAS or the BRAF gene.
CAR-T therapy has shown promising results in treating melanoma patients, with some patients experiencing significant improvements in their condition. However, more research is needed to fully understand the effectiveness of this treatment in a larger population of melanoma patients.
Melanoma Research was created in 1991.
Omholt, K., A. Platz, L. Kanter, et al. "NRAS and BRAF Mutations Arise Early During Melanoma Pathogenesis and Are Preserved Throughout Tumor Progression." Clinical Cancer Research 9 (December 15, 2003): 6483-6488.
Combining biologic or immunologic agents such as interferon with standard chemotherapeutic agents is under study and showing improved response rates.
Giulio Costanzi has written: 'Malignant Melanoma 1 (Cancer Treatment and Research)' 'Dati biografici ed elenco ragionato delle pubblicazioni fino al dicembre 1946' -- subject(s): Aeronautics, Bibliography
The Prospective Malignant Pleural Mesothelioma Staging Project is a research program that studies MPM and attempts to re-classify the different stages of the disease. Proper staging and understanding can assist with giving the right treatment to patients.
a
A good place to conduct research on Alzhimers is to find a clinic that has patients with Alzhimers disease and ask for their permission to do a research.
Doctors treat diseases and research the causes of diseases. They take care of patients.
information released in 2002 showed that treatment with arginine improved immune function in HIV patients and proved safe for these patients when used on a short-term patients.
With this new breakthrough in cancer research, many patients will be saved.
taking blood samples from patients for research purpose without consent